SR-A-174 is a SARS-CoV-2 MPro inhibitor with an IC50 of 0.060 µM. SR-A-174 has limited cell permeability and exhibits low activity in cells expressing MPro-eGFP, with a cellular IC50 > 10 µM. SR-A-174 can be used in COVID-19-related research[1].
Molecular Weight:
426.12
Formula:
C19H12Cl4N2O
Target:
SARS-CoV,Virus Protease
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted